Ottawa Hospital Research Institute

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Ottawa Hospital Research Institute sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials 1 currently recruiting 7 completed later-stage tilt upper quartile by trial count

Ottawa Hospital Research Institute: 8 sponsored US clinical trials, 1 recruiting.

Ottawa Hospital Research Institute sponsors 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 7 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hip Dysplasia, with 1 trials.

Upper-quartile sponsor footprint

Ottawa Hospital Research Institute sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

8 total, page 1 of 1

RECRUITING NA

Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

NCT03481010
COMPLETED

Validation of Handheld Ultrasound Devices in Rheumatology

NCT06580886
COMPLETED NA

SAHaRA: A Randomized Controlled Trial

NCT03309579
COMPLETED Phase 3

PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot

NCT01274637
COMPLETED

Weaning And Variability Evaluation

NCT01237886
COMPLETED Phase 4

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

NCT00967304
COMPLETED

Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism

NCT00788736
COMPLETED Phase 3

TIPPS: Thrombophilia in Pregnancy Prophylaxis Study

NCT00967382

Phase Distribution

PhaseTrial count
Phase 3 2
Phase 4 1

Therapeutic Areas

Hip Dysplasia 1
Thrombophilia 1
Pregnancy Complications 1
Pregnancy 1

Where Ottawa Hospital Research Institute enrollment is open (later-stage tilt)

1 recruiting of 8 indexed (13% open); 7 completed (88%).

Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Hip Dysplasia (1 trial), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Ottawa Hospital Research Institute: open-pipeline peers nationwide

Peers matched on 8 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

Ottawa Hospital Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 681012141618 0%10%20%30%40% Total trials Recruiting share Ottawa Hospital Research InstituteAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Addario Lung Cancer Medical InstituteAmerican UniversityAnnexonAnsun Biopharma
Ottawa Hospital Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Ottawa Hospital Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Ottawa Hospital Research Institute page

8 registered trials is a research-attention snapshot, not an endorsement of Ottawa Hospital Research Institute or any single study.

  • 1 of Ottawa Hospital Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hip Dysplasia is the condition Ottawa Hospital Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hip Dysplasia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Ottawa Hospital Research Institute pipeline card: 8 registered trials from official public datasets.Report a data error.